SESSION I: COLORECTAL & ESOPHAGEAL DISEASES
8-minute presentation, 7-minute discussion

Moderators:

Vic Velanovich, MD Gregory Kennedy, MD

ADJUVANT CHEMOTHERAPY IN OLDER PATIENTS WITH LOCALLY ADVANCED COLON CANCER: IS LESS MORE?
Julia Frebault¹, ², Alexander Troester¹, Michael Horsey¹, Sarah Mott³, Schelomo Marmor¹, Arjun Gupta¹, Imran Hassan⁴, Pridvi Kandagatla⁵, Paolo Goffredo^1
1University of Minnesota Twin Cities, Minneapolis, MN, United States, ²Hennepin County Medical Center, Minneapolis, MN, United States, ³University of Iowa Hospitals and Clinics, Iowa City, IA, United States, ⁴MercyOne, Des Moines, IA, United States, ⁵Allina Health, Minneapolis, MN, United States

POSTOPERATIVE ANTIBIOTICS IN PEDIATRIC PERFORATED APPENDICITIS: COMPARATIVE OUTCOMES WITH MONOTHERAPY VS. MULTI-DRUG COVERAGE
Jaclyn R. Dempsey, Aakash Srikanth, Geetha Radhakrishnan, Ravi Radhakrishnan
Surgery, University of Texas Medical Branch, Galveston, TX, United States

MODIFYING THE GUT MICROBIOTA WITH PREBIOTICS STRENGTHENS THE GUT BARRIER AND PREVENTS THE DISSEMINATION AND GROWTH OF COLORECTAL CANCER CELLS
Roy Hajjar¹, ², Ayodeji S. Ajayi¹, ², Manon Oliero¹, ², Gabriela Fragoso¹, Annie Calve¹, Thibault Cuisiniere¹, ², Claire McCartney¹, ², Ahmed Amine Alaoui¹, ², Nassima Taleb¹, Claire Gerkins¹, ², Carole Richard², ¹, Manuela M Santos², ^1
1Centre de Recherche du Centre Hospitalier de l'Universite de Montreal, Montreal, QC, Canada, ²Universite de Montreal, Montreal, QC, Canada

LONG-TERM OUTCOMES OF HYBRID ENDOSCOPIC SUBMUCOSAL DISSECTION IN A TERTIARY CARE CENTER
Salih N. Karahan, Mustafa Oruc, Kamil Erozkan, Joshua Sommovilla, Scott Steele, Emre Gorgun
Colorectal Surgery, Cleveland Clinic, Cleveland, OH, United States

EXPONENTIAL SURGE IN ANTIREFLUX SURGERY UTILIZATION IN THE UNITED STATES: RESULTS FROM A 25-YEAR NATIONWIDE POPULATION-BASED ANALYSIS
Daniel M. Simadibrata¹, Ronnie Fass^2
1Department of Medicine, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, United States, ²Division of Gastroenterology and Hepatology, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, United States

EVALUATING LYON CONSENSUS 2.0 VS. DEMEESTER SCORE: PREDICTIVE ACCURACY OF ESOPHAGEAL ACID EXPOSURE CRITERIA FOR ANTIREFLUX SURGERY OUTCOMES
Sven Eriksson¹, ³, Inanc Sarici¹, ³, Amanda Scobie¹, Nicholas Belleza¹, Mara Fryer¹, Ping Zheng¹, Shahin Ayazi¹, ², ^3
1Foregut Division, Surgical Institute, Allegheny Health Network, Pittsburgh, PA, United States, ²Department of Surgery, Drexel University, Philadelphia, PA, United States, ³Chevalier Jackson Research Fellowship, Esophageal Institute, Western Pennsylvania Hospital, Allegheny Health Network, Pittsburgh, PA, United States

THE IMPACT OF GAS BLOAT SYNDROME ON OUTCOMES AFTER NISSEN FUNDOPLICATION AND ITS ASSOCIATION WITH ANATOMICAL FAILURE AND NEED FOR REVISIONAL SURGERY
Inanc Sarici¹, ³, Sven Eriksson¹, ³, Johnathan Nguyen¹, Naveed Chaudhry¹, Ping Zheng¹, Shahin Ayazi¹, ², ^3
1Foregut Division, Surgical Institute, Allegheny Health Network, Pittsburgh, PA, United States, ²Department of Surgery, Drexel University, Philadelphia, PA, United States, ³Chevalier Jackson Research Fellowship, Esophageal Institute, Western Pennsylvania Hospital, Allegheny Health Network, Pittsburgh, PA, United States

THE PADOVA CLASSIFICATION IN ACTION: AN INTERNATIONAL STUDY ON POST-FUNDOPLICATION OUTFLOW OBSTRUCTION (PFOO)
Francesca Forattini¹, Khanh Hoang Nicholas Le², Luca Provenzano¹, Matteo Santangelo¹, Giovanni Capovilla¹, Arianna Vittori¹, Matteo Pittacolo¹, Loredana Nicoletti¹, Lucia Moletta¹, Michele Valmasoni¹, Rena Yadlapati², Renato Salvador^1
1Department of Surgical, Oncological and Gastroenterological Sciences, Universita degli Studi di Padova, Padova, Veneto, Italy, ²University of California San Diego, San Diego, CA, United States

PERORAL ENDOSCOPIC MYOTOMY AND LAPAROSCOPIC HELLER MYOTOMY SHOW SIMILAR OUTCOMES IN TYPE III ACHALASIA
Archana Jeeji, Alexander S. Farivar, Emily M. Mackay, Adam J. Bograd, Peter T. White, Brian E. Louie
Thoracic Surgery, Swedish Medical Center, Seattle, WA, United States

SESSION II: HEPATOBILIARY DISEASES
8-minute presentation, 7-minute discussion

Moderator:

Motaz Qadan, MD

POSTOPERATIVE CTDNA IS ASSOCIATED WITH OUTCOMES AFTER CURATIVE-INTENT HEPATECTOMY: RESULTS FROM THE INTERCEPT PROGRAM
Brittany C. Fields, Antony Haddad, Yifan Wang, Elsa M. Arvide, Deborah E. Mrema, Kristin D. Alfaro-Munoz, Robert J. Kell, Van Karlyle Morris, Arvind Dasari, Tsuyoshi Konishi, Yun Shin Chun, Hop S. Tran Cao, Ching-Wei D. Tzeng, Scott Kopetz, Jean-Nicolas Vauthey, Timothy E. Newhook
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States

ASSOCIATION OF ELEVATED CA19-9 AND OUTCOMES AFTER CURATIVE-INTENT HEPATECTOMY FOR COLORECTAL LIVER METASTASES: AN INTERNATIONAL EXPERIENCE
Elena Panettieri¹, ², Antony Haddad², Andrea Campisi¹, Jace P. Landry², Agostino Maria De Rose¹, Francesco Ardito¹, Hop S. Tran Cao², Ching-Wei D. Tzeng², Yun Shin Chun², Felice Giuliante¹, Jean-Nicolas Vauthey², Timothy E. Newhook^2
1Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Lazio, Italy, ²The University of Texas MD Anderson Cancer Center, Houston, TX, United States

TUMOR BURDEN PREDICTS OUTCOMES AFTER CURATIVE RESECTION OF MULTIFOCAL INTRAHEPATIC CHOLANGIOCARCINOMA
Jun Kawashima¹, ², Miho Akabane¹, Zayed Rashid¹, Abdullah Altaf¹, Selamawit Woldesenbet¹, Mujtaba Khalil¹, Azza Sarfraz¹, Diamantis Tsilimigras¹, Odysseas Chatzipanagiotou¹, François Cauchy³, Federico Aucejo⁴, Hugo P. Marques⁵, Tom Hugh⁶, Feng Shen⁷, Shishir K. Maithel⁸, B. Groot Koerkamp⁹, Irinel Popescu¹⁰, Minoru Kitago¹¹, Matthew Weiss¹², Guillaume Martel¹³, Carlo Pulitano¹⁴, Luca Aldrighetti¹⁵, George A. Poultsides¹⁶, Andrea Ruzzenente¹⁷, Todd W. Bauer¹⁸, Ana Gleisner¹⁹, Itaru Endo², Timothy M. Pawlik^1
1The Ohio State University Wexner Medical Center, Columbus, OH, United States, ²Yokohama Shiritsu Daigaku, Yokohama, Kanagawa, Japan, ³Hospital Beaujon, Clichy, Île-de-France, France, ⁴Cleveland Clinic, Cleveland, OH, United States, ⁵Hospital Curry Cabral, Lisboa, Lisboa, Portugal, ⁶The University of Sydney, Sydney, NSW, Australia, ⁷Shanghai Eastern Hepatobiliary Surgery Hospital, Shanghai, China, ⁸Emory University, Atlanta, GA, United States, ⁹Erasmus Universiteit Rotterdam, Rotterdam, Zuid-Holland, Netherlands, ¹⁰Institutul Clinic Fundeni, Bucuresti, Romania, ¹¹Keio Gijuku Daigaku, Minato-ku, Tokyo, Japan, ¹²Northwell Health Feinstein Institutes for Medical Research, Manhasset, NY, United States, ¹³University of Ottawa, Ottawa, ON, Canada, ¹⁴Royal Prince Alfred Hospital, Camperdown, NSW, Australia, ¹⁵IRCCS Ospedale San Raffaele, Milano, Italy, ¹⁶Stanford University, Stanford, CA, United States, ¹⁷Universita degli Studi di Verona, Verona, Veneto, Italy, ¹⁸University of Virginia, Charlottesville, VA, United States, ¹⁹University of Colorado Denver, Denver, CO, United States

CLINICAL AND MOLECULAR FEATURES OF YOUNG-ONSET INTRAHEPATIC CHOLANGIOCARCINOMA: A MULTI-INSTITUTIONAL ANALYSIS
Adriana C. Gamboa¹, Elena Panettieri¹, Yun Shin Chun¹, Ashton A. Connor³, Milind Javle², Timothy E. Newhook¹, Shubham Pant², Hop S. Tran Cao¹, Ching-Wei D. Tzeng¹, Jean-Nicolas Vauthey^1
1The University of Texas MD Anderson Cancer Center Division of Surgery, Houston, TX, United States, ²The University of Texas MD Anderson Cancer Center Gastrointestinal Cancer Center, Houston, TX, United States, ³Houston Methodist, Houston, TX, United States

INTRODUCTION TO KEYNOTE SPEAKER
Zhi Ven Fong, MD, MPH
Mayo Clinic, Phoenix, Arizona

KEYNOTE ADDRESS
CONNECTING THE DOTS: EVIDENCE-BASED HEALTH POLICY
Thomas Tsai, MD, MPH
Brigham and Women’s Hospital, Boston, MA

SESSION III: PANCREATIC & PAWS DISEASES
8-minute presentation, 7-minute discussion

Moderators:

Taylor Riall, MD Trang Nguyen, MD

SPECIFIC TARGETING OF PANCREATIC CANCER IN ORTHOTOPIC MOUSE MODELS WITH AN ANTI CA-19-9 ANTIBODY CONJUGATED TO A NIR FLUOROPHORE
Javier Bravo¹, Kristin E. Cox¹, Sunidhi Jaiswal¹, Siamak Amirfakhri¹, Thinzar Lwin³, Sumbal Talib², Maneesh Jain², Robert Hoffman¹, Aaron Mohs², Surinder Batra², Michael Bouvet^1
1Surgery, UC San Diego, San Diego, CA, United States, ². University of Nebraska Medical Center, Omaha, NE, United States, ³City of Hope, Duarte, CA, United States

INDUCIBLE GENETIC MOUSE MODEL OF INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM USING IN VIVO ADENO-ASSOCIATED VIRUS WITH CRISPR-CAS9
Hannah N. Rinehardt¹, Alexander Kolodychak², Alexis Martyn¹, Vinitha Dhamotharan¹, Alexander Kreger³, Madison Thomas¹, Lydia Liszewski¹, Andrew Kolodychak⁴, Ting Zhang¹, George Gittes^1
1Pediatric Surgery, Children's Hospital of Pittsburgh John G Rangos Sr Research Center, Pittsburgh, PA, United States, ²Brown University Warren Alpert Medical School, Providence, RI, United States, ³UH Cleveland Medical Center, Cleveland, OH, United States, ⁴University of Notre Dame, Notre Dame, IN, United States

BIDIRECTIONAL PACLITAXEL PLUS NILOTINIB FOR PERITONEAL CARCINOMATOSIS: PHASE II CLINICAL TRIAL RESULTS
Shruthi R. Perati, Amber F. Gallanis, Stephanie Canady, Molly Sullivan, Nancy Moore, Yvonne Mallory, Audra Satterwhite, Diane Ahn, Silvia Figueiroa Da Cruz, Stacy Joyce, John Lee, Andre De Souza, Jessica Mukherjee, Sarah Shin, Ning Ma, Lamin Juwara, Jibran Ahmed, Alice Chen, Jeremy L. Davis, Andrew Blakely
National Cancer Institute, National Institutes of Health, Bethesda, MD, United States

TUMOR DNA ANALYSIS IN PERITONEAL FLUID TO DETECT AND MONITOR PERITONEAL CARCINOMATOSIS
Muhammad Talha Nawaz⁵, ¹, Muhammad Talha Waheed⁴, Kirsten Dennison⁵, ¹, ², Bradon Mcdonald¹, ⁵, ², Stephanie McGregor³, ², Syed Nabeel Zafar¹, ², Mustafa Raoof⁴, Muhammed Murtaza¹, ⁵, ^2
1University of Wisconsin-Madison Department of Surgery, Madison, WI, United States, ²University of Wisconsin-Madison Carbone Cancer Center, Madison, WI, United States, ³University of Wisconsin-Madison Department of Pathology and Laboratory Medicine, Madison, WI, United States, ⁴City of Hope Department of Surgery, Riyadh, Riyadh Province, Saudi Arabia, ⁵Center for Human Genomics & Precision Medicine, University of Wisconsin-Madison, Madison, WI, United States

SESSION IV: STOMACH/BARIATRIC/METABOLIC
8-minute presentation, 7-minute discussion

Moderator:

Anne Lidor, MD

CRACKING THE CODE: KEY FACTORS INFLUENCING RECURRENCE TIMING AFTER HIATAL HERNIA REPAIR
Mikhail Attaar, Bradley Kushner, Michael M. Awad
Surgery, Washington University in St Louis School of Medicine, St. Louis, MO, United States

CARDIOVASCULAR RISK REDUCTION IN A LARGE COHORT STUDY: COMPARATIVE OUTCOMES OF SLEEVE GASTRECTOMY, ROUX-EN-Y GASTRIC BYPASS, AND BILIOPANCREATIC DIVERSION SURGERIES
Wissam Ghusn¹, ², Tala Abedalqader², Nour El Ghazal², Noura Jawhar², Donna Abboud², Simon J Laplante², Eric J. Vargas², Andres Acosta², Omar M. Ghanem^2
1Internal Medicine, Boston University, Boston, MA, United States, ²Mayo Clinic Minnesota, Rochester, MN, United States

OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES WITH MASH AND MASLD: A COMPARISON BETWEEN BARIATRIC SURGERY AND GLP-1 AGONISTS
Zehra Naseem¹, Varun Aitharaju¹, Aun Muhammad², Arjun Chatterjee¹, Stephen A. Firkins¹, Roma Patel¹, Akash Khurana¹, Roberto Simons-Linares¹, Bailey Flora¹, Erika Staneff¹, Rehan Haidry^3
1Internal Medicine, Cleveland Clinic, Cleveland, OH, United States, ²The University of Mississippi Medical Center, Jackson, MS, United States, ³Cleveland Clinic London Ltd, London, England, United Kingdom

THE DIABETES REMISSION INDEX (DRI): AN INNOVATIVE PREDICTIVE MODEL FOR DIABETES REMISSION AFTER METABOLIC PROCEDURES
Wissam Ghusn¹, ³, Pearl Ma², Robert A. Vierkant³, Manpreet Mundi³, Matyas Fehervari⁴, Kayla Ikemiya², Karl Hage⁵, Andres Acosta³, Michael Camilleri³, Barham Abu Dayyeh³, Kelvin Higa², Omar M. Ghanem^3
1Internal Medicine, Boston University, Boston, MA, United States, ²University of California San Francisco Department of Medicine Fresno, Fresno, CA, United States, ³Mayo Foundation for Medical Education and Research, Rochester, MN, United States, ⁴Imperial College London, London, United Kingdom, ⁵Cleveland Clinic, Cleveland, OH, United States

ROUX-EN-Y GASTRIC BYPASS IS ASSOCIATED WITH INCREASED RISK OF OSTEOPOROTIC FRACTURES AT 10-YEARS POST-SURGERY: RESULTS OF A MULTINATIONAL MULTICENTER ANALYSIS
Donghyun Ko³, Do Han Kim², Wilhelm S. Basegoda⁴, Jose A. Porres⁵, Paul T. Kröner⁶, Christopher C. Thompson^1
1Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Boston, MA, United States, ²Mount Sinai Morningside Hospital, New York, NY, United States, ³Bridgeport Hospital, Bridgeport, CT, United States, ⁴University of South Alabama, Mobile, AL, United States, ⁵Universidad Francisco Marroquin Facultad de Medicina, Guatemala City, Guatemala Department, Guatemala, ⁶Riverside Health System, Newport News, VA, United States

TRENDS IN GLP-1 RECEPTOR AGONIST UTILIZATION AND BARIATRIC SURGERY RATES: A REAL-WORLD ANALYSIS FROM 2021-2024
Ahmed Telbany, Evelyn Inga, Pooja Viswanath, Abhishek Patel, Gulshan Parasher
Gastroenterology & Hepatology, University of New Mexico Health Sciences Center, Albuquerque, NM, United States

INTERNATIONAL CONNECTIONS RECEPTION & AWARD ANNOUNCEMENT
San Diego Convention Center
Tortuga Room